Will My Insurance Cover Wegovy or Zepbound? A Guide to Commercial Coverage in Georgia

By Dr. Don Gates, MD, Founder of Scale Solutions

If you have insurance through an employer, coverage for weight-loss medication varies enormously from plan to plan — and the most important thing to understand is that many employer plans exclude weight-loss drugs entirely, as a benefit design choice, regardless of your BMI, your health conditions, or what your physician documents.

That is not the same as being told you need prior authorization. One is a closed door; the other is a form. Patients confuse the two constantly, spending months on appeals that were never going to succeed or giving up on a plan that would have covered them. Here is how to tell which one you have, and what to do in either case.

Key Takeaways

• A plan exclusion is not a medical decision. Your employer or plan sponsor made it, not a clinician reviewing your chart.
• Coverage tracks employer size. In KFF’s 2025 employer survey, 16% of firms with 200–999 workers, 30% with 1,000–4,999, and 43% with 5,000 or more covered GLP-1 agonists used primarily for weight loss.
• Two documents answer your question: your Summary of Benefits and Coverage and your plan’s formulary.
• If your plan does cover it, expect prior authorization — BMI thresholds, a documented weight-related condition, evidence of lifestyle intervention, sometimes step therapy through an older medication.
• Manufacturer copay cards can bring a covered prescription to as little as $25 a month, but they carry savings caps and exclude anyone with Medicare, Medicaid, TRICARE or VA coverage.

The One Distinction That Decides Everything: Exclusion vs. Prior Authorization

A formulary or benefit exclusion means your plan does not pay for that drug — or that entire category — under any circumstances. A prior authorization requirement means your plan does pay, once you document that you meet its criteria.

CMS defines these in the standardized glossary every plan must use. Excluded services are “health care services that your plan doesn’t pay for or cover.” A formulary is “a list of drugs your plan covers.” Prior authorization is “a decision by your health insurer or plan that a health care service, treatment plan, prescription drug or durable medical equipment (DME) is medically necessary.”

At the pharmacy counter both produce the same experience: your card is rejected and you are quoted full retail. But prior authorization is a documentation problem, and a physician who has actually evaluated you can usually solve it. A written exclusion is a contract problem, and clinical documentation changes nothing — because no one has questioned your clinical need in the first place.

Employers weigh the cost of a medication many employees may take indefinitely: 66% of firms with 5,000 or more workers that covered GLP-1s for weight loss told KFF it had a “significant” impact on drug spending. Coverage is moving rather than static, though — among the largest firms it rose from 28% to 43% in a single year. Re-check your own plan each open enrollment.

Self-funded vs. fully insured — and why Georgia law may not help

Most large employers do not buy insurance; they pay claims themselves and hire an insurance company to administer the plan. CMS describes a self-insured plan as one where “the employer collects contributions from employees via payroll deductions and takes on the responsibility of paying all related medical claims,” versus a fully insured plan “purchased by an employer from an insurance company.”

The consequence: “Self-insured plans are regulated by the federal government and are generally not subject to state insurance laws.” If you are hoping a state mandate will force your employer’s hand, a self-funded plan generally would not be bound by one. I could not verify any Georgia statute requiring commercial plans to cover weight-loss medication, and this article does not claim one exists.

Your Blue Cross, UnitedHealthcare, Aetna or Cigna card tells you who administers your plan — not who designed the benefit.

How to Find Out Exactly What Your Own Plan Covers

Steps 1–2 tell you whether the category is covered at all. Steps 3–5 tell you what approval requires.

Step 1 — Open your Summary of Benefits and Coverage (SBC)

Every group health plan must give you an SBC in a standardized federal format containing a section titled “Excluded Services and Other Covered Services.” Plans must sort a specified list into either box, and that list includes bariatric surgery and weight loss programs.

⚠️ A critical trap: “weight loss programs” means programs, not prescription drugs. Its placement proves nothing about your medication either way. The SBC is where you start, not where you finish — its real value is that it must “provide a direct link or URL address to the formulary drug list.”

Step 2 — Request your Summary Plan Description (SPD)

The SPD is the long document, and it is where category-level drug exclusions are actually written. The Department of Labor calls it “the primary document that gives information about the plan, what benefits are available under the plan,” and requires it to describe “whether, and under what circumstances, existing and new drugs are covered.”

Request it from your plan administrator, usually HR. Search for: weight, obesity, anorexiant, anti-obesity, GLP-1, exclusions. A line like “drugs prescribed for weight reduction are not covered” ends the question.

Step 3 — Look up the drug by name on the formulary

Search the specific brand — Wegovy, Zepbound, Saxenda, Foundayo — and read the code beside it. The legend is usually on the first or last page.

If the drug does not appear at all, that is meaningful but not conclusive. Call and confirm.

Step 4 — Call the pharmacy benefit manager, not the medical plan

The pharmacy benefits number is usually printed separately on the back of your card. Ask these and write down the answers:

1. “Is [drug name] covered under my pharmacy benefit for chronic weight management?” Say weight management, not diabetes — a drug can be covered for one indication and excluded for the other.
2. “Is this a benefit exclusion under my employer’s plan design, or is it covered with prior authorization?” This is the most valuable question on the list.
3. “What are the prior authorization criteria, and can you send the criteria document or PA form to me or my prescriber?”
4. “Is there a step therapy requirement, and which medications satisfy it?”
5. “What tier is it on, what is my copay or coinsurance after the deductible, and is there a quantity limit?”
6. “Is one of these drugs preferred over the other, and must it be filled at a specific specialty or mail-order pharmacy?”
7. “When does my plan year reset, and is a formulary change scheduled?”
8. “May I have a reference number for this call?” Always get it — a documented call is evidence if you later appeal.

Step 5 — Bring the answer to your prescriber

Arriving at a visit already holding the plan’s criteria moves approval along considerably faster. Arriving knowing the category is excluded turns the visit into an equally useful conversation about medications your plan does cover and about self-pay pathways.

Prior Authorization: What Plans Typically Require

If your plan covers weight-loss medication, expect to document clinical criteria before the first fill — and to re-document periodically.

Criteria vary but commonly build on the FDA-approved indication. The Zepbound prescribing information (revised 4/2026) indicates it as an adjunct to a reduced-calorie diet and increased physical activity for adults with obesity (BMI ≥30 kg/m²) or overweight (BMI 27–<30 kg/m²) with a comorbid condition such as “dyslipidemia, hypertension, obstructive sleep apnea, or cardiovascular disease,” and separately for moderate-to-severe obstructive sleep apnea in adults with obesity. Wegovy’s weight-management indication is similarly structured around BMI thresholds with at least one weight-related condition.

Beyond the label, plans frequently require:

• A documented BMI from a recorded office visit, sometimes a baseline plus a recheck
• A documented weight-related condition, coded and supported in the chart
• Evidence of lifestyle intervention over a defined period
• Enrollment in a program — KFF found 34% of covering firms “require enrollees to meet with a dietitian, case manager, or therapist, or participate in a lifestyle program in order to receive the coverage”
• Step therapy through an older agent
• Reauthorization, often requiring demonstrated weight loss to continue

Why documentation from a physician who has evaluated you matters

Prior authorization is a documentation exercise. What satisfies a reviewer is a real longitudinal record: measured weights over time, a coded diagnosis, labs where clinically appropriate, documented counseling, and reasoning a reviewer can follow. That record is a natural byproduct of ongoing care and is difficult to assemble retroactively.

It also protects you at renewal. The 2026 Standards of Care in Overweight and Obesity recommend (grade A) continuing obesity medications after treatment goals are reached, “as discontinuation often results in weight recurrence and worsening or reemergence of cardiometabolic risk factors or obesity-related diseases and complications.” When a plan asks a year later whether continued therapy is justified, a documented course of care is what answers it.

Related: a real clinical record built over time.

What Is Step Therapy, and Why Would My Plan Require an Older Drug First?

Step therapy is a plan rule requiring you to try one or more lower-cost medications before it will pay for a costlier one. It is a cost-management tool applied at the plan level, not tailored to you individually.

For weight management it typically routes patients through older agents first — phentermine, phentermine/topiramate (Qsymia), naltrexone/bupropion (Contrave), orlistat, or liraglutide (Saxenda), available as a generic in the U.S. since 2025. Note that generic liraglutide’s listed pricing is not currently competitive with manufacturer self-pay prices for the newer agents, so “generic” does not automatically mean cheapest here.

Two honest points. Step therapy is not automatically a bad clinical outcome — these medications are FDA-approved and some patients respond well at a fraction of the cost. And plans generally allow exceptions: if you have already tried and failed a required agent, or have a contraindication, that history can often satisfy or bypass the step, but only if it is documented.

For a fuller comparison of the options a step-therapy rule may route you through, see our guide to weight-loss medications that are not GLP-1s.

If You Are Denied: How Appeals Actually Work

Federal appeal rights work well against medical-necessity denials. They rarely move a written benefit exclusion — so identify which one you received first.

For a group health plan subject to federal claims and appeals rules, you generally have 180 days from receipt of the denial to file an internal appeal. The plan must decide within 15 calendar days for a pre-service claim (which a prescription prior authorization typically is), 30 calendar days post-service, and a maximum of 72 hours for urgent care. If the internal appeal fails, you generally have at least four months to request an independent external review, and that decision “is binding on plan or issuer and claimant.”

What makes an appeal succeed: a letter of medical necessity addressing the plan’s own written criteria point by point, documented BMI and comorbidities, documented prior treatment attempts and outcomes, and where useful a peer-to-peer call between your physician and the plan’s reviewer.

What an appeal cannot do: overturn an exclusion your employer wrote into the plan. If the denial letter cites a benefit exclusion rather than medical necessity, the productive paths are your employer’s benefits committee at open enrollment, a spouse’s plan if available, or self-pay.

Manufacturer Savings Cards When You Do Have Commercial Coverage

Program terms verified August 19, 2026. These change frequently — confirm current terms on the manufacturer’s site before relying on them.

Know what “maximum savings” means before budgeting around it. The $25 figure applies if your plan’s cost-share is low enough that the card’s monthly cap closes the gap. If your plan puts the drug on a high tier with a $400 monthly copay and the card’s monthly maximum is $100, you pay $300 — not $25. Have the pharmacy run the card and quote you the real number.

Everyone with government coverage is excluded. Lilly’s terms require that “you are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE®/CHAMPUS.” Novo’s Wegovy offer likewise excludes government-insured patients. This is a legal requirement, not a technicality.

What Happens When Your Coverage Changes

Plan year and open enrollment. Benefit design typically resets at the start of the plan year. That is the one window when weight-loss drug coverage can be added, dropped or restricted — and the one window when asking HR actually influences anything.

Mid-year formulary changes. A drug list is not frozen for twelve months. Plans and pharmacy benefit managers can move drugs between tiers, add prior authorization or step therapy, or drop products mid-year, usually with notice mailed to members. If benefits mail looks like boilerplate, read it anyway.

Changing jobs, or moving. A new employer means a new plan design, a new formulary, and a prior authorization process starting from zero — even for a medication you have taken successfully for two years. Before leaving a job, request copies of your prior authorization approval letters and ask your physician’s office for records documenting BMI history, comorbidities, treatment course and response. That packet is what makes the next approval fast. The same applies to relocation — our guide to transferring GLP-1 care when you move covers what to gather and in what order.

Georgia-Specific Coverage Situations

Georgia State Health Benefit Plan (SHBP)

If you are a state employee, public school employee or covered dependent, weight-loss prescriptions are now routed through a designated vendor. SHBP states: “This benefit is mandatory for any members with a new weight loss prescription and those members currently receiving coverage of any weight loss prescription drugs upon expiration of their current prior authorization period.”

It applies to members enrolled through Anthem (HRA or HMO) or UnitedHealthcare (HDHP or HMO); Kaiser Permanente members are excluded. The requirement covers weight-loss prescriptions — the Anthem and UnitedHealthcare Georgia provider bulletins confirm it excludes diabetes GLP-1s such as Ozempic and Mounjaro. Because SHBP covers Savannah-Chatham County Public Schools, Georgia Southern/Armstrong and state agencies across Chatham, Bryan, Effingham and Liberty counties, this affects many local families. Our dedicated SHBP article covers the mechanics.

Georgia Medicaid

Georgia Medicaid does not cover medications for weight loss. The state’s approved plan amendment lists among excluded outpatient drug categories, verbatim: “Agents used for anorexia, weight loss or weight gain.” GLP-1s appear on the Georgia Preferred Drug List only within the diabetes class.

TRICARE

Prime, Select, Young Adult, Reserve Select, Retired Reserve and CHCBP beneficiaries generally have coverage for weight-loss medications with an approved prior authorization, a network prescriber and a network pharmacy. TRICARE For Life, direct-care-only and NATO/Partnership for Peace beneficiaries lost that coverage effective August 31, 2025. Given Fort Stewart and Hunter Army Airfield, this matters locally — see our TRICARE guide rather than applying commercial-plan logic to a TRICARE benefit.

Medicare — a short pointer

If you have Medicare, this is not your page. Part D coverage of weight-loss medication runs through an entirely separate structure, including the Medicare GLP-1 Bridge Program that opened July 1, 2026, with its own eligibility criteria and its own significant fine print. Read our Medicare GLP-1 Bridge guide for Georgia instead — the commercial rules, savings cards and appeal timelines above do not apply to you.

If Your Plan Excludes Weight-Loss Medication Entirely

A written exclusion is disappointing but not the end of the conversation. Every manufacturer of a currently approved GLP-1 for weight management now sells directly to self-pay patients at prices well below list, and older non-GLP-1 medications remain inexpensive. Rather than repeat price tables here, see our self-pay pricing guide, which carries verification dates for each manufacturer program.

When to Talk to Your Doctor

Insurance questions and clinical questions overlap but are not the same. Bring these to a physician, not a benefits line:

• Before starting the process, if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 — GLP-1 medications for weight management are contraindicated in these situations, which makes the coverage question moot.
• If you are pregnant, planning pregnancy, or breastfeeding. All approved obesity medications are contraindicated in pregnancy, and current guidance is to stop obesity medication at least two months before a planned pregnancy.
• If step therapy would route you toward a medication you previously reacted badly to — that history needs documenting, and the exception request comes from your prescriber.
• If you are on treatment and coverage is ending — worth a conversation before the last fill, not after.

Seek urgent or emergency care — do not wait on an insurance question — for severe, persistent abdominal pain, especially radiating to the back and with vomiting (possible pancreatitis); signs of a severe allergic reaction such as swelling of the face, lips or tongue, or difficulty breathing; persistent vomiting with inability to keep fluids down; or any new vision change. Also tell your physician about mood changes and about new or unusual skin sensations such as burning, tingling or heightened skin sensitivity, which appear in current labeling for semaglutide products.

Scale Solutions & Coastal Georgia

Commercial coverage here is unusually concentrated. Between Gulfstream, the Hyundai Metaplant supplier network across Bryan, Bulloch, Chatham, Effingham and Liberty counties, the Savannah hospital systems and the State Health Benefit Plan, most local patients with employer insurance sit inside one of a relatively small number of plans — each with its own formulary, criteria and quirks. That is the kind of knowledge a local practice accumulates by working with the same plans repeatedly.

It is also why documentation matters. Approvals and reauthorizations are built from a real clinical record — measured weights across visits, a coded diagnosis, appropriate labs, documented counseling — and that record is a natural product of ongoing care with a physician who examines you, follows your response, and is still there a year later when the plan asks whether continued therapy is justified.

If you live in Savannah, Pooler, Richmond Hill, Hinesville, Rincon, Statesboro or anywhere in Coastal Georgia and you are trying to work out what your employer plan actually covers — or you have a denial letter and cannot tell whether it was an exclusion or a documentation problem — you are welcome to contact Scale Solutions. We are glad to help you identify which situation you are in and what your realistic options are, whether or not you end up as a patient here.

Related: check whether you meet the BMI criteria.

Related: the broader Georgia GLP-1 cost and insurance landscape.

Frequently Asked Questions

How do I tell whether my plan excludes weight-loss drugs or just requires prior authorization? Call the pharmacy benefits number on your card and ask directly: “Is this a benefit exclusion under my employer’s plan design, or is it covered with prior authorization?” Then confirm it in writing by finding the language in your Summary Plan Description. Only one of those two answers is worth appealing.

What BMI do plans usually require for Wegovy or Zepbound? Most build their criteria on the FDA-approved indication — generally a BMI of 30 or higher, or 27 to just under 30 with a weight-related condition such as dyslipidemia, hypertension, obstructive sleep apnea or cardiovascular disease. Individual plans may set stricter thresholds, so ask for your plan’s written criteria rather than assuming label criteria apply.

Can my insurance stop covering Zepbound mid-year? Yes. Drugs can move tiers, gain prior authorization or step therapy requirements, or be removed during a plan year. Plans typically mail notice to affected members, which is one reason to read benefits correspondence.

My employer doesn’t cover weight-loss medication. Does Georgia law require them to? We could not verify any Georgia statute requiring commercial plans to cover weight-loss medication, and this article does not claim one exists. Note also that most large employers self-fund, and CMS states self-insured plans “are regulated by the federal government and are generally not subject to state insurance laws.”

How much will I actually pay with a savings card if my plan covers the drug? Potentially as little as $25 a month — but only if your plan’s cost-share is low enough that the card’s monthly cap closes the gap. The Zepbound and Foundayo cards cap savings at $100 per one-month fill, and the Wegovy offer is subject to a maximum savings of $100 per month. If your copay exceeds that, you pay the difference. (Verified August 19, 2026.)

Can I use a manufacturer savings card if I have Medicare or TRICARE? No. These programs explicitly exclude anyone enrolled in a state, federal or government-funded healthcare program, including Medicare, Medicare Advantage, Medicaid, TRICARE, VA and DoD coverage. Medicare beneficiaries have a separate pathway, and TRICARE has its own rules.

How long do I have to appeal a denial? Generally 180 days from receipt of the denial to file an internal appeal, and the plan must decide a pre-service claim within 15 calendar days. If that fails, you generally have at least four months to request an independent external review, and that reviewer’s decision is binding on the plan.

I’m a Georgia state or school employee. Do these rules apply to me? Partly. SHBP members with weight-loss prescriptions are routed through the plan’s designated weight-management vendor, which SHBP describes as mandatory for new prescriptions and for existing members when their current prior authorization expires. Diabetes GLP-1s such as Ozempic and Mounjaro are not covered by that requirement.

Conclusion

Whether your commercial plan covers Wegovy or Zepbound comes down to a decision your employer made about benefit design — and you can find that decision in writing in about fifteen minutes, in your Summary of Benefits and Coverage, your Summary Plan Description and your formulary. If the category is covered, the work shifts to documentation: meeting prior authorization criteria, satisfying or excepting step therapy, and building the clinical record that supports the first approval and every renewal after it. If the category is excluded, appeals will not move it, and your energy is better spent on open enrollment or a self-pay pathway.

If you are in Savannah or Coastal Georgia and your benefit paperwork has become the obstacle — a formulary that makes no sense, a denial letter you cannot interpret, or documentation a prior authorization needs — reach out to Scale Solutions. Sorting out coverage is a routine part of what we do alongside the medical care, and we would rather help you get a clear answer than see you give up on treatment because a benefits document was confusing.

MEDICAL SOURCES & FURTHER READING

1. FDA / DailyMed — ZEPBOUND (tirzepatide) injection, Prescribing Information. Label revised 4/2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b (FDA-approved indication and BMI thresholds.)

2. FDA — Drugs@FDA: FDA-Approved Drugs. https://www.accessdata.fda.gov/scripts/cder/daf/ (Approval status of liraglutide generics and non-GLP-1 weight-management agents; verified August 19, 2026.)

3. CMS — Glossary of Health Coverage and Medical Terms (Uniform Glossary). Revised June 7, 2023. https://www.cms.gov/files/document/uniform-glossary-english-060723.pdf (Definitions of formulary, prior authorization, excluded services, appeal.)

4. CMS — Health Insurance Basics. https://www.cms.gov/files/document/nsa-health-insurance-basics.pdf (Self-insured vs. fully insured plans; applicability of state insurance laws.)

5. CMS — Internal Claims and Appeals and the External Review Process Overview. https://www.cms.gov/marketplace/technical-assistance-resources/internal-claims-and-appeals.pdf (180-day internal appeal window; 15/30-day and 72-hour decision timeframes; four-month external review window; binding effect.)

6. U.S. Department of Labor, EBSA — Workers’ Rights to Health Plan Information. https://www.dol.gov/sites/dolgov/files/ebsa/about-ebsa/our-activities/resource-center/fact-sheets/workers-rights-health-plan-information.pdf (Summary Plan Description contents, including drug coverage disclosure.)

7. U.S. Department of Labor — Summary of Benefits and Coverage: Instruction Guide for Group Health Plan Coverage. https://www.dol.gov/sites/dolgov/files/EBSA/laws-and-regulations/laws/affordable-care-act/for-employers-and-advisers/sbc-group-health-plan-instructions-3.pdf (Required “Excluded Services and Other Covered Services” section; required formulary link.)

8. Georgia Medicaid State Plan Amendment GA-24-0001. Effective January 1, 2024; CMS-approved June 6, 2024. https://www.medicaid.gov/medicaid/spa/downloads/GA-24-0001.pdf (Exclusion of “Agents used for anorexia, weight loss or weight gain.”)

9. Gudzune KA, et al.; ADA Professional Practice Committee for Obesity. “Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity.” Published January 13, 2026. DOI 10.2337/doci25-0008. https://pmc.ncbi.nlm.nih.gov/articles/PMC12815056/ (Recommendation 2.16, grade A, on continuing therapy after goals are reached.)

10. KFF — 2025 Employer Health Benefits Survey, Summary of Findings. https://files.kff.org/attachment/Employer-Health-Benefits-Survey-2025-Annual-Survey-Summary-of-Findings.pdf (Coverage rates by firm size; lifestyle-program requirements; drug spending impact.)

11. Georgia State Health Benefit Plan — Weight Management Program. https://shbp.georgia.gov/plan-options-programs/pharmacy/9amhealth-weight-management-program (Mandatory routing language and plan eligibility.)

12. Eli Lilly — Zepbound Coverage & Savings. https://www.zepbound.lilly.com/coverage-savings (Commercial savings card terms; verified August 19, 2026.)

13. Eli Lilly — Foundayo (orforglipron) Coverage & Savings. https://foundayo.lilly.com/coverage-savings (Commercial savings card terms; verified August 19, 2026.)

14. NovoCare — Wegovy Savings Offer Program. https://www.novocare.com/patient/medicines/wegovy/savings-offer.html (Commercial savings offer terms; verified August 19, 2026.)

15. Scale Solutions Editorial Policy. https://scale-solutions.com/editorial-policy/